![CME Programme CSHK mw_menu_data_5564_56eb2b174e5e3.jpg](https://cshk.org/site/CSHK/upload/mw_menu_data/file/mw_menu_data_5564_56eb2b174e5e3.jpg)
CME Programme
-
Non-Regular Activities
Triple negative breast cancer: Updates in immunotherapyDate: 29/06/2022 Enquiries: Global Medical and Scientific Affairs Department, Merck Sharp & Dohme (Asia) Ltd. CME Points Awarded: 1.5 points